Sundrug Revenue

Sundrug had revenue of 210.74B JPY in the quarter ending September 30, 2025, with 4.83% growth. This brings the company's revenue in the last twelve months to 824.66B, up 6.32% year-over-year. In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B with 6.66% growth.

Revenue (ttm)

824.66B

Revenue Growth

+6.32%

P/S Ratio

0.60

Revenue / Employee

115.42M

Employees

7,145

Market Cap

497.53B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	801.81B	50.03B	6.66%
Mar 31, 2024	751.78B	61.32B	8.88%
Mar 31, 2023	690.46B	41.73B	6.43%
Mar 31, 2022	648.73B	14.42B	2.27%
Mar 31, 2021	634.31B	16.54B	2.68%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,213.71B
HOYA Corporation	892.50B
Takeda Pharmaceutical Company	4,417.00B
Daiichi Sankyo Company	1,978.88B
Otsuka Holdings	2,418.53B
Astellas Pharma	2,006.82B
Terumo	1,062.42B
Shionogi &	437.26B

Revenue Rankings